Truist Financial Corp Trims Position in Integer Holdings Corporation $ITGR

Truist Financial Corp cut its position in Integer Holdings Corporation (NYSE:ITGR) by 58.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 11,179 shares of the medical equipment provider’s stock after selling 15,871 shares during the quarter. Truist Financial Corp’s holdings in Integer were worth $877,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Salomon & Ludwin LLC increased its stake in shares of Integer by 46.8% in the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 118 shares in the last quarter. Farther Finance Advisors LLC boosted its position in shares of Integer by 193.2% during the fourth quarter. Farther Finance Advisors LLC now owns 519 shares of the medical equipment provider’s stock worth $41,000 after acquiring an additional 342 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Integer by 210.5% during the second quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after acquiring an additional 362 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Integer by 861.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 692 shares of the medical equipment provider’s stock worth $85,000 after acquiring an additional 620 shares during the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Integer by 166.2% during the fourth quarter. GAMMA Investing LLC now owns 1,134 shares of the medical equipment provider’s stock worth $89,000 after acquiring an additional 708 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Zacks Research lowered shares of Integer from a “hold” rating to a “strong sell” rating in a research report on Monday, May 11th. Truist Financial upped their target price on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th. Raymond James Financial restated an “outperform” rating and set a $101.00 target price on shares of Integer in a research report on Monday, February 23rd. Wall Street Zen lowered shares of Integer from a “buy” rating to a “hold” rating in a research report on Sunday, January 25th. Finally, Citigroup dropped their target price on shares of Integer from $92.00 to $89.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Four research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Integer presently has an average rating of “Hold” and an average price target of $98.29.

Integer Price Performance

ITGR stock opened at $88.15 on Monday. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $123.78. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. The company has a fifty day simple moving average of $86.23 and a two-hundred day simple moving average of $80.99. The firm has a market capitalization of $2.99 billion, a P/E ratio of 21.98, a price-to-earnings-growth ratio of 2.08 and a beta of 0.67.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a net margin of 7.64% and a return on equity of 12.83%. The business had revenue of $439.58 million for the quarter, compared to the consensus estimate of $426.48 million. During the same quarter last year, the business earned $1.31 EPS. Integer’s revenue for the quarter was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Analysts anticipate that Integer Holdings Corporation will post 6.11 earnings per share for the current fiscal year.

Insider Activity

In other news, VP Tommy P. Thomas sold 825 shares of the firm’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the sale, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This trade represents a 15.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.10% of the company’s stock.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.